FISCHER
Fischer Medical Ventures share price & financials
- Price
- ₹39.27
- Market cap
- ₹2.5k Cr
- Sector
- Healthcare
Quarterly results
Q1 FY27: revenue up 249.5%, net profit down 22.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 40 | 12 | 49 | 23 | 86 +118% | 101 +760% | 98 +98% | 82 +249% |
| EBITDA | 1 | 0 | 3 | 4 | 16 +3144% | 22 +5730% | -4 −250% | 11 +182% |
| Net profit | 0 | -0 | 1 | 5 | 14 +4693% | 19 +6731% | -12 −1050% | 4 −22% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −69.1% 1Y
1Y: ₹116.09 on 10 Sept 2025 → ₹35.87. High ₹117.71 (31 Oct 2025), low ₹31.21 (9 Jun 2026).
Financials, as filed
Revenue grew 285.1% a year over 2 years, FY24 to FY26. Operating margin widened to 12.3%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹21 Cr | ₹111 Cr | ₹308 Cr |
| Operating profit | ₹2 Cr | ₹3 Cr | ₹38 Cr |
| Operating margin | 10.9% | 2.9% | 12.3% |
| Interest | ₹0 Cr | ₹0 Cr | ₹6 Cr |
| Depreciation | ₹0 Cr | ₹2 Cr | ₹3 Cr |
| Net profit | ₹2 Cr | ₹1 Cr | ₹26 Cr |
| Net margin | 10.8% | 1.1% | 8.3% |
| Cash from operations | ₹-7 Cr | ₹-87 Cr | ₹-101 Cr |
| Free cash flow | ₹-8 Cr | ₹-93 Cr | ₹-103 Cr |
| ROCE | 5.0% | 1.0% | 11.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹54 Cr | ₹65 Cr | ₹65 Cr |
| Reserves | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹28 Cr | ₹295 Cr | ₹319 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹30 Cr | ₹107 Cr |
| Other liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹77 Cr | ₹180 Cr |
| Total liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹86 Cr | ₹468 Cr | ₹672 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹15 Cr | ₹31 Cr | ₹33 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹121 Cr | ₹123 Cr |
| Other assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹70 Cr | ₹313 Cr | ₹513 Cr |
| Total assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹86 Cr | ₹468 Cr | ₹672 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Aug 2026
Since Sep 2025, promoters added +1.29 pp while the public trimmed −1.13 pp. The shareholder count grew 83% to 23,951.
- Promoters
- 63.1%
- FIIs
- 5.6%
- DIIs
- 1.3%
- Public
- 30.1%
Since Sep 2025
- Promoters +1.29 pp
- Public −1.13 pp
- DIIs −0.16 pp
How it drifted, 12 quarters
Over this window the public fell from 100.0% to 30.1% — −69.9 pp.
Ownership split by quarter, oldest first. Dec '23: Public 100.0%.Mar '24: FIIs 5.1%, DIIs 1.7%, Public 93.2%.Jun '24: Promoters 74.9%, FIIs 5.1%, DIIs 1.7%, Public 18.3%.Sep '24: Promoters 74.9%, FIIs 5.1%, DIIs 1.7%, Public 18.3%.Dec '24: Promoters 74.9%, FIIs 5.1%, DIIs 1.7%, Public 18.3%.Mar '25: Promoters 62.8%, FIIs 5.2%, DIIs 1.4%, Public 30.5%.Jun '25: Promoters 61.8%, FIIs 5.5%, DIIs 1.4%, Public 31.2%.Sep '25: Promoters 61.8%, FIIs 5.6%, DIIs 1.4%, Public 31.2%.Dec '25: Promoters 61.8%, FIIs 4.8%, DIIs 1.4%, Public 32.0%.Mar '26: Promoters 62.1%, FIIs 5.0%, DIIs 1.4%, Public 31.5%.Jun '26: Promoters 62.1%, FIIs 5.5%, DIIs 1.4%, Public 31.0%.Aug '26: Promoters 63.1%, FIIs 5.6%, DIIs 1.3%, Public 30.1%.
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Vritti Hitesh Kawa newly disclosed 1.03% held
- Shankar Varadharajan +0.85 pp 12.31% held
- Vikasa India Eif I Fund FPI fund +0.27 pp 2.81% held
- FMV Holdings Pte Ltd +0.09 pp 50.78% held
The same filing shows 9 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Aug 2026 filing
Every holder of Fischer Medical Ventures Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| FMV Holdings Pte Ltd | 50.78% | +0.09 pp |
| Shankar Varadharajan | 12.31% | +0.85 pp |
| Vikasa India Eif I Fund FPI fund | 2.81% | +0.27 pp |
| Roopal Hitesh Kawa . | 2.54% | −0.17 pp |
| India Emerging Giants Fund Limited FPI fund | 2.32% | −0.16 pp |
| Vinay Rajendrakumar Nagda | 1.43% | −0.10 pp |
| Blue Lotus Capital Multi Bagger Fund Ii AIF | 1.26% | −0.09 pp |
| L7 Hitech Private Limited | 1.17% | −0.08 pp |
| Kaushik Hasmukhlal Gandhi | 1.14% | −0.07 pp |
| Natwarlal Keshavjibhai Kawa | 1.11% | −0.07 pp |
| Vritti Hitesh Kawa | 1.03% | newly disclosed |
| Hitesh Natwarlal Kawa | 1.02% | −0.07 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Fischer Medical Ventures Limited
Guides on how to read this kind of business and the numbers that matter.